Sex and gender (%) | | | |
Male | 100 | 100 | |
Female | 0 | 0 | |
Age (yr) | 49±11 | 50±9 | p=0.91) |
Time from onset to surgery (mo) | 31±21 | 30±21 | p=0.91) |
Pattern of pain (%) | | | |
Continuous | 40 | 33 | p=0.852) |
Intermittent | 60 | 67 | |
Alcohol abuse (%) | 80 | 100 | p=0.42) |
BMI (kg/m2) | 19±2 | 19±2 | p=0.91) |
Weight (kg) | 52±11 | 50±8 | p=0.71) |
ASA class (%) | | | |
I | 0 | 0 | |
II | 100 | 100 | |
III | 0 | 0 | |
Pseudocyst (%) | 60 | 0 | p=0.092) |
Mean diameter of bile duct (mm) | 14±4 | 15±5 | p=0.81) |
Mean diameter of pancreatic duct (mm) | 11±5 | 11±1 | p=0.91) |
Mean diameter of pancreatic head (mm) | 31±4 | 32±3 | p=0.81) |
Surgical procedure (%) | | | |
Extended partington | 0 | 100 | |
Frey | 100 | 0 | |
Mean operative time (min) | 244±71 | 257±71 | p=0.81) |
Mean blood loss (mL) | 130±45 | 117±29 | p=0.61) |
Preoperative Izbicki score | 64 (55–68) | 59 (44–58) | p=0.43) |
Preoperative SF-12 PCS | 42 (0–58) | 29 (13–79) | p=0.73) |
Preoperative SF-12 MCS | 62 (28–83) | 29 (18–86) | p=0.43) |
Preoperative endocrine insufficiency (%) | 20 | 33 | p=12) |
Preoperative exocrine insufficiency (%) | 20 | 0 | p=12) |
Nausea (%) | 40 | 67 | p=12) |
Weight loss (%) | 60 | 100 | p=0.52) |
Anorexia (%) | 40 | 33 | p=12) |